Abstract
Three-dimensional culture systems bridge the experimental gap between in vivo and in vitro physiology. However, nonstandardized formation and limited downstream adaptability of 3D cultures have hindered mainstream adoption of these systems for biological applications, especially for low- and moderate-throughput assays commonly used in biomedical research. Here we build on our recent development of a 384-well hanging drop plate for spheroid culture to design a complementary spheroid transfer and imaging (TRIM) plate. The low-aspect ratio wells of the TRIM plate facilitated highfidelity, user-independent, contact-based collection of hanging drop spheroids. Using the TRIM plate, we demonstrated several downstream analyses, including bulk tissue collection for flow cytometry, high-resolution low working-distance immersion imaging, and timely reagent delivery for enzymatic studies. Low working-distance multiphoton imaging revealed a cell type–dependent, macroscopic spheroid structure. Unlike ovarian cancer spheroids, which formed loose, disk-shaped spheroids, human mammary fibroblasts formed tight, spherical, and nutrient-limited spheroids. Beyond the applications we describe here, we expect the hanging drop spheroid plate and complementary TRIM plate to facilitate analyses of spheroids across the spectrum of throughput, particularly for bulk collection of spheroids and high-content imaging.
Keywords: 3D tissue spheroids, high-throughput imaging, and hanging drop spheroids
Introduction
Many cell culture applications are moving toward more physiological 3D model systems to bridge the gap between nonphysiological 2D platforms and in vivo conditions. Mass transport of drugs, nutrients, and metabolites in these systems is more representative of profiles of parameters such as hypoxia and metabolism. Despite these advantages, previous technologies for spheroid cultures were not used extensively due to lack of throughput (e.g., microfluidics), limited spheroid uniformity (e.g., rotating flasks), and cumbersome nonstandardized handling and analysis. Challenges to standardization, implementation, and analysis of 3D tissue cultures have limited widespread adoption.1 Comparison and standardization of spheroid formation systems is also necessary to reconcile observed differences in gene expression and respiratory status for spheroids formed in hanging as compared with microfluidic systems.2
To address many of these issues, we developed a 384 hanging drop plate for high-throughput formation and analysis of individual and uniform spheroids.3,4 Our hanging drop system consists of 384 through-holes to facilitate formation of uniform spheroids and ready access to the medium via the through-hole to exchange media, add treatments, or add cells at defined time points. Other groups have developed systems for hanging drop formation that rely on gravity-enforced cell assembly.5 The simplest but least stable strategy for hanging drop formation is to plate droplets on the underside of nonadherent culture dishes.6 The company, InSphero (Schlieren, Switzerland), also developed a 96-well gravity-driven hanging drop system that uses a similar through-hole strategy as our 384-well plate.7,8 Many imaging-based analyses, however, require a spheroid to be transferred to a secondary dish for stable focusing. High-fidelity transfer of hanging drop spheroids to a fixed substrate for downstream analysis requires highly parallel and consistent pipetting, which is inefficient and time-consuming by hand and costly to automate. While the InSphero GravityTrap system enables transfer of 96-well array format hanging drop spheroids to a secondary 96-well plate substrate, it disallows immersionbased imaging and facile bulk collection.
Here we report the development of a transfer and imaging (TRIM) plate to expand the usefulness of the 384 hanging drop system and facilitate these previously difficult downstream analyses. We differentiate our system from the InSphero system based on increased throughput (384-vs. 96-well array format) and low aspect transfer wells that facilitate high-fidelity spheroid capture, immersion-based imaging, bulk spheroid collection, and timely enzyme-substrate kinetic studies.
Materials and Methods
Plate Design
We used SolidWorks (Dassault Systèmes SolidWorks Corp., Waltham, MA) to conceptualize the TRIM plate in three dimensions. We fabricated the TRIM plate in the material Accura 60 (3DSystems, Rock Hill, SC) using the SLA Viper si2 dual-resolution SLA system, which is conducted by the University of Michigan Medical Innovation Center. The dimensions of the 384 wells are a total depth of 1.25 mm, which serves as the optical working distance, and a total well diameter of 4 mm. The wells are formatted as a standard 384-well plate to match the 384 hanging drop plate with a 16-by-24 array spaced every 4.5 mm. The inner-wall dimensions of the original 384 hanging drop plate match the outer wall of the TRIM plate and serve as physical guides for high-fidelity matching between droplets and wells. We developed a multiradial well contour to facilitate settling of the spheroid in the center of the well while limiting spheroids sticking in corners due to surface tension (Suppl. Fig. S2). Around the periphery of the plate, a 2-mm ridge guides medium overflow during bulk spheroid collection.
Cells and Spheroid Cultures
We cultured all cells in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and 1% antibiotic. We used several cell types to form spheroids, including MDA-MB-231 breast cancer cells (ATCC, Manassas, VA), HeyA8 ovarian cancer cells (gift of Gordon Mills, MD Anderson Cancer Center, Houston, TX), and a human mammary fibroblast cell line expressing green fluorescent protein (GFP).9 We transduced HeyA8 ovarian cancer cells with a lentiviral vector for GFP and sorted for a population of stably transduced cells by flow cytometry.10 We previously have described MDA-MB-231 cells stably expressing eqFP650, GFP, or firefly luciferase.11 We formed and maintained spheroids in 25 µL of culture medium as we described previously using the 384 hanging drop plate.3,4
Contact-Based Spheroid Transfer and Collection
To transfer hanging drop spheroids, we aligned the TRIM plate based on designed plate guides and lowered the hanging drop plate to contact the TRIM plate (Fig. 1A–D). We allowed spheroids to settle into the transfer wells for 1 to 2 min to improve transfer efficiency. We evenly lifted and separated the hanging drop plate from the recipient TRIM plate for spheroid transfer. See Supplemental Video V1 for demonstration of drop transfer.
Figure 1.
Transfer and imaging of 384 hanging drop spheroids. (A) Schematic representation of the hanging drop plate and complementary transfer and imaging (TRIM) plate. The circle in A defines the region detailed in B. (C) Schematic depiction of hanging drop plate transfer with user-independent alignment guides. The circle in C defines the region detailed in D, showing contact-dependent drop transfer. (E) Example images of the residual dye in the hanging drop plate (top) after transfer to the TRIM plate (bottom). The inset shows the bottom view of the hanging droplets prior to transfer. (F) Example image of 500-µm spheroids transferred from the hanging drop plate to the TRIM plate. Spheroids were stained with trypan blue for 4 h prior to transfer to improve image contrast.
Spheroid Analysis and Imaging
For two-photon imaging of spheroids, we used a 25× objective (XLPLN, NA: 1.05; Olympus, Center Valley, PA) and an upright confocal and two-photon microscope (Olympus MPE Twin) as we have described before.12 We imaged individual HeyA8 spheroids and HMF spheroids both containing 15,000 cells per droplet. We very gently immersed the TRIM plate in growth medium after spheroid transfer for upright immersion microscopy. For imaging, we maintained resolution and z-step increment but varied the laser intensity between HMF and HeyA8 spheroids due to differences in their overall fluorescent intensity.
We collected 100 spheroids containing 10,000 cells total with different ratios (1:1 and 1:9) of 231 cells expressing either nuclear-GFP or FP650 for flow cytometry analysis (Fig. 2). To collect spheroids, we transferred them to the TRIM plate and used ~50 mL of DMEM culture medium to wash spheroids from the TRIM plate into a 50-mL conical tube. We centrifuged the spheroids and resuspended the pellet in 0.25% trypsin with EDTA. Once spheroids were dissociated, we neutralized trypsin with full DMEM, centrifuged the sample, and resuspended the cells in phosphate-buffered saline (PBS) for flow cytometry analysis. Flow cytometry was done using a Becton Dickinson (Franklin Lakes, NJ) FACS DiVa Flow Cytometer. We set the sort quadrants with an excitation at 488 and 633 nm based on fluorescencenegative MDA-MB-231 cells (Fig. 2B). The quadrant statistics were determined with the Becton Dickinson software.
Figure 2.
Spheroid collection for analysis by flow cytometry. (A) We co-seeded spheroids with MDA-MB-231 cells at ratios of 9:1 and 1:1 of cells expressing FP650 or green fluorescent protein (GFP), respectively. Schematic of spheroid collection by directing pipette flow into each well and collecting the overflow. After collection, centrifugation, and spheroid dissociation, we performed flow cytometry. FACS, fluorescence-activated cell sorting. (B–F) Flow cytometry scatter plots show MDA-MB-231 cells with no fluorescent protein (B), FP650 only (C), GFP only (D), and 9:1 (E) and 1:1 (F) ratios of FP650 and GFP cells, respectively. Note that we compare the top two quartiles with the bottom quartiles to estimate the relative seeding of FP650 and GFP cells to capture the heterogeneity of the FP650 cells.
For bioluminescence imaging, we seeded 154 spheroids (every other well in 384 wells) containing 10,000 cells per drop total at a ratio of 9:1 HMF cells and MDA-MB-231 cells expressing firefly luciferase. We plated water in the outer wells to minimize evaporation. Prior to transfer of spheroids to the TRIM plate, we added 3 µL of 15 mg/mL luciferin diluted 4× in phosphate-buffered saline to each corresponding well on the TRIM plate. Contact between the spheroid droplet and the preplated luciferin caused simultaneous mixing of all transferred droplets. We quantified the number of wells with detectable bioluminescence of firefly luciferase as we have described before (Suppl. Fig. S1).13
We stained HMF spheroids with trypan blue after 3 to 4 days of culture to increase contrast by staining for dead cells. To stain the cells, we added 2 µL of 4× dilution of trypan blue in PBS to each droplet for 4 h prior to transfer. We exchanged 10 µL of media twice to remove the residual trypan blue in each droplet. After transfer, we imaged the TRIM plate with a white light back light using a 5-MP camera (Fig. 1F).
Results and Discussion
Spheroid Transfer and Imaging
The TRIM plate structure is complementary to the 384 hanging drop plate designed by our group with designs to enable (1) gentle, high-fidelity, contact-based drop and spheroid transfer; (2) bulk spheroid collection; and (3) high-resolution imaging with short optical working-distance objectives (Figs. 1, 2, and 3, respectively). The low aspect ratio of our plate is markedly different from the InSphero GravityTrap system, which disallows immersion imaging and bulk collection.7 We designed low-aspect ratio wells less than 2 mm in depth, which is less than the height of the hanging 25-µL droplets for contact-based drop transfer and low working-distance immersion imaging (Fig. 1D). A visual demonstration with dyed droplets illustrates the simple high-fidelity transfer process using 384 droplets (Fig. 1E,F and Suppl. Video V1). The residual volume of liquid (~5 µL) remains in the 384 hanging drop plate (Fig. 1E, top), but spheroids localize to the bottom of the droplet by gravity and transfer robustly (Fig. 1F).
Figure 3.
Three-dimensional imaging with the transfer and imaging (TRIM) plate. (A) Example two-photon z-stack image of a large spheroid of HeyA8 ovarian cancer cells expressing green fluorescent protein (GFP) and (B) the corresponding cross section with the location denoted by the dotted line in A. (C) Example two-photon z-stack image of a large spheroid of HMF-expressing GFP spheroid and (D) the corresponding cross section with the location denoted by the dotted line in A. Arrows (B, D) denote the upward direction toward the objective. Unlike the ovarian cancer spheroid, the HMF spheroid is dense and nutrient limited, resulting in lower internal fluorescence intensity, denoted by an asterisk (D, H). Schematics of the spheroid morphology show HeyA8 spheroids to curve with the droplet radius (E) and the HMF spheroid to be spherical (F). Loose interactions between HeyA8 cells are permissive to nutrient transport within the spheroid (G), but tight intracellular forces limit transport into the spheroid (H).
We demonstrate 100% spheroid capture efficiency (154/154) based on the number of bioluminescent spheroids that transferred to TRIM plate wells containing the preplated enzymatic substrate, luciferin (Suppl. Fig. S1). The benefit of measuring bioluminescence in spheroids was 2-fold. First we provided a quantitative demonstration of robust spheroid transfer, where only existing spheroids expressing firefly luciferase that transferred to wells with preplated luciferin emitted a signal. Second, we highlighted the simultaneous initiation of bioluminescence kinetics for all spheroids via addition of enzymatic substrate to the spheroids at a discrete time. The timing and kinetics of enzyme-substrate interactions are critical to many assays. Also, the magnitude and trajectory of the signal from an enzymatic assay in spheroids may be limited by enzyme concentration, substrate or ligand concentration, diffusion into the cell, or diffusion into the spheroid. For researchers performing time-sensitive kinetics assays without access to an automated liquid handler, simultaneous administration of reagents is a distinct advantage. Rather than pipetting substrate or ligand into individual hanging drop wells in a time-dependent manner, the TRIM plate enables facile and simultaneous administration of luciferin substrate to initiate measurements for kinetic assays. We envision using this strategy for administration of ligand and/or luciferase substrate for more advanced bioluminescence applications, such as quantifying ligand-receptor interactions or intracellular signaling in spheroids.14 In this situation, we could use a multichannel or single pipette to dispense the ligand into the receiving plate, followed by initiation of signaling at the time of spheroid transfer.
One challenge with analysis of adherence-independent cultures such as spheroids is to physically but reversibly immobilize the sample to minimize movement and facilitate organized downstream analysis. We highlight these challenges particularly for immersion imaging, where sample stability is at a premium and imaging in the hanging drop plate is impossible. Transfer of spheroids to a rigid substrate enhanced stability and allowed for immersion imaging. Although transfer to standard culture dishes is possible, movement due to flow in standard culture formats disrupts imaging. To improve this, we implemented a multicurvature well contour (Suppl. Fig. S2) to facilitate settling of the spheroid to the direct center of each well (Fig. 1F), rather than to the peripheral edges of standard flat-bottom dishes. We found our well depth was optimal for low working-distance objectives but provided adequate resistance to spheroid movement by fluid flow. Organized transfer maintains the experimental setup of multiple conditions and enables imaging of spheroid conditions sequentially without losing track of particular conditions and the experiment organization.
Spheroid Collection and Analysis
Standard 2D cell culture platforms are amenable to subcellular, single-cell, and population analysis. While 3D and high-resolution imaging applications discussed above address the two former analysis scales, population analysis for population-, DNA-, RNA-, protein-, and metabolite-level assays requires high efficiency recovery of many cells, which is difficult in most 3D culture formats. We used the TRIM plate to collect bulk spheroids simultaneously for dissociation and analysis using flow cytometry. After transfer of spheroids, we released them by tilting the TRIM plate, directing flow from a pipette down into the wells, and collecting the overflow in a 50-mL conical tube (Fig. 2A). Following enzymatic dissociation of the spheroids with trypsin, we analyzed spheroids containing 1:9 and 1:1 ratios of 231 cells expressing either GFP or FP650 (Fig. 2C,D). We note that the FP650 cells were not homogeneously expressing, causing them to show up in both bottom quadrants of the flow cytometry plot. However, these are still intensity shifted for FP650 relative to the negative control (Fig. 2C–E). Our flow cytometry analysis closely matched the proportion of 1:1 and 1:9 for GFP to FP650 by summing the bottom quadrants for the FP650 cells and top quadrants for the GFP cells (Fig. 2E,F).
High-Resolution 3D Imaging
Since the spheroid settles to the lower curvature and is relatively fixed, we demonstrate imaging of the 3D volume of large spheroids using two-photon microscopy (Fig. 3A–D) for HeyA8 ovarian cancer (Fig. 3A,B) and HMF spheroids, both expressing GFP. We note the hemispherical disk shape of the ovarian cancer “spheroid” to be striking (Fig. 3B), as the perception of a spheroid is understandably spherical. The HMF cells formed a smaller, tight structure with largely spherical morphology. The density of the HMF spheroid also led to metabolic limitations in the center of the spheroid, which we speculate decreased protein synthesis and resulted in lower GFP intensity. Based on the morphology of the spheroids, the shape of the HeyA8 spheroid seems to be physically dictated by the droplet radius (Fig. 3E,G). Others have observed disk-like ovarian cancer spheroids that were formed in hanging droplets and cite the importance of defining the geometric spheroid morphology.15 The strong intracellular forces between the HMF cells, on the other hand, lead to a tight spherical shape (Fig. 3F,H). Others have defined nutrient transfer limitations and hypoxia in 3D cell spheroids for structures more than ~100 to 200 µm in diameter.16 However, nutrient limitations are very much cell type and spheroid shape dependent and must be characterized for new cells at the onset of a project. For defining nutrient limitations and hypoxia, the complementary hanging drop and TRIM plates enable 3D multiphoton image-based screening of many combinations of cell types and conditions in parallel.
Future Directions and Opportunities
Widespread adoption of 3D tissue culture is dependent on three aspects: ease of use, standardization, and scale. We previously developed a 384-well hanging drop plate to improve standardization of spheroid culture and spheroid uniformity. However, it is biased toward facilitating high-throughput analyses, such as robotic automation and standard plate reader assays. Efficient tools for recovery of spheroids will broaden applicability of hanging drop spheroids and encompass the full spectrum of throughput, from high-throughput analysis to low- and moderate-throughput analyses, such as high-resolution imaging and flow cytometry. We used the TRIM plate to demonstrate facile handling for high-resolution imaging of individual spheroids and flow cytometric analysis of bulk-collected spheroids. The TRIM plate improves compatibility of hanging drop spheroids with low- and moderate-throughput analyses that are bioassay staples. We believe these systems substantially improve the utility of spheroid cultures for biomedical research, bridging the gap between low-throughput in vivo models and standard 2D tissue culture systems.
Supplementary Material
Acknowledgments
We thank Sasha Cai Lesher-Perez for useful discussion of spheroid cultures and their analysis and handling. We also thank Michael Deininger, from the University of Michigan, Medical Innovation Center, for useful discussion of considerations for 3D prototyping.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by U.S. National Institutes of Health grants R01CA170198, R01CA136553, R01CA136829, R01CA142750, and P50CA093990. S.P.C. was supported on Advanced Proteome Informatics of Cancer Training Grant T32 CA140044.
Footnotes
Supplementary material for this article is available on the Journal of Laboratory Automation Web site at http://jla.sagepub.com/supplemental.
Declaration of Conflicting Interests
The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: S.T. has licensed the 384 hanging drop array technology to 3D Biomatrix and also has stock options.
References
- 1.Mehta G, Hsiao AY, Ingram M, et al. Opportunities and Challenges for Use of Tumor Spheroids as Models to Test Drug Delivery and Efficacy. J. Control. Release. 2012;164:192–204. doi: 10.1016/j.jconrel.2012.04.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zhou Y, Arai T, Horiguchi Y, et al. Multi-Parameter Analyses of Three-Dimensionally Cultured Tumor Spheroids Based on Respiratory Activity and Comprehensive Gene-Expression Profiles. Anal. Biochem. 2013;439:187–193. doi: 10.1016/j.ab.2013.04.020. [DOI] [PubMed] [Google Scholar]
- 3.Hsiao AY, Tung YC, Qu X, et al. 384 Hanging Drop Arrays Give Excellent Z-Factors and Allow Versatile Formation of Co-culture Spheroids. Biotechnol. Bioeng. 2012;109:1293–1304. doi: 10.1002/bit.24399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tung YC, Hsiao AY, Allen SG, et al. High-Throughput 3D Spheroid Culture and Drug Testing Using a 384 Hanging Drop Array. Analyst. 2011;136:473–478. doi: 10.1039/c0an00609b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kelm JM, Fussenegger M. Microscale Tissue Engineering Using Gravity-Enforced Cell Assembly. Trends Biotechnol. 2004;22:195–202. doi: 10.1016/j.tibtech.2004.02.002. [DOI] [PubMed] [Google Scholar]
- 6.Laib AM, Bartol A, Alajati A, et al. Spheroid-Based Human Endothelial Cell Microvessel Formation In Vivo. Nat. Protocols. 2009;4:1202–1215. doi: 10.1038/nprot.2009.96. [DOI] [PubMed] [Google Scholar]
- 7.Drewitz M, Helbling M, Fried N, et al. Towards Automated Production and Drug Sensitivity Testing Using Scaffold-Free Spherical Tumor Microtissues. Biotechnol. J. 2011;6:1488–1496. doi: 10.1002/biot.201100290. [DOI] [PubMed] [Google Scholar]
- 8.Waschow M, Letzsch S, Boettcher K, et al. High-Content Analysis of Biomarker Intensity and Distribution in 3D Microtissues. Nat. Methods. 2012;9 [Google Scholar]
- 9.Orimo A, Gupta PB, Sgroi DC, et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion. Cell. 2005;121:335–348. doi: 10.1016/j.cell.2005.02.034. [DOI] [PubMed] [Google Scholar]
- 10.Smith MCP, Luker KE, Garbow JR, et al. CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer. Cancer Res. 2004;64:8604–8612. doi: 10.1158/0008-5472.CAN-04-1844. [DOI] [PubMed] [Google Scholar]
- 11.Luker KE, Mihalko LA, Schmidt BT, et al. In Vivo Imaging of Ligand Receptor Binding with Gaussia Luciferase Complementation. Nat. Med. 2012;18:172–177. doi: 10.1038/nm.2590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Salomonnson E, Mihalko LA, Verkhusha VV, et al. Cell-Based and In Vivo Spectral Analysis of Fluorescent Proteins for Multiphoton Microscopy. J. Biomed. Opt. 2012;17:96001. doi: 10.1117/1.JBO.17.9.096001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Miao Z, Luker KE, Summers BC, et al. CXCR7 (RDC1) Promotes Breast and Lung Tumor Growth In Vivo and Is Expressed on Tumor-Associated Vasculature. Proc. Natl. Acad. Sci. U. S. A. 2007;104:15735–15740. doi: 10.1073/pnas.0610444104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Luker KE, Gupta M, Luker GD. Imaging CXCR4 Signaling with Firefly Luciferase Complementation. Anal. Chem. 2008;80:5565–5573. doi: 10.1021/ac8005457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Das T, Meunier L, Barbe L, et al. Empirical Chemosensitivity Testing in a Spheroid Model of Ovarian Cancer Using a Microfluidics-Based Multiplex Platform. Biomicrofluidics. 2013;7:011805. doi: 10.1063/1.4774309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Serganova I, Doubrovin M, Vider J, et al. Molecular Imaging of Temporal Dynamics and Spatial Heterogeneity of Hypoxia-Inducible Factor-1 Signal Transduction Activity in Tumors in Living Mice. Cancer Res. 2004;64:6101–6108. doi: 10.1158/0008-5472.CAN-04-0842. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



